Breakthrough surgery could delay the menopause for up to 20 years ​​​​​​​

By - World Healthcare Journal

Breakthrough surgery could delay the menopause for up to 20 years ​​​​​​​

In a small-scale study, ten British women have undergone a newly developed surgery that has the potential to delay the menopause by up to 20 years.

The menopause currently negatively affects millions of women around the world in varying ways, causing serious health complications for some, such as osteoporosis, heart conditions and increased risk of infections - which can then develop into even more serious conditions.

However, with this new treatment there is now the ability to eliminate the danger of these health risks and reduce the emotional, mental, and physical issues that the menopause causes which can last for years.

The 30-minute operation involves surgically removing a piece of the woman's ovaries, and then cryogenically freezing it at -150 C. As the woman begins to reach the age of menopause and feel its effects, the tissue is then unfrozen and re-implanted, which replicates the hormone levels from when the patient was younger - thereby tricking the body into believing it is far younger than it actually is.

The procedure is currently being offered privately through ProFaM, a fertility and menopause centre based in Birmingham. It is available to women until the age of 40. The full cost of the treatment ranges from £3,000 to £7,000 for the removal and cryogenic freezing of an ovary, and then a further £4,000 for the transplant of the tissue back into the body.

One of the ten women who underwent the treatment, a 34-year-old married mother, says that she wanted to avoid having to take Hormone Replacement Therapy in the future which can increase risks of certain cancers.

“I have to say I've never felt any pain, and it seems quite miraculous that it's something so straightforward,” she told The Sunday Times.

Professor Fishel, one of the pioneers of the project was also a member of the original research team involved in the development of IVF treatment. Throughout his career, he has contributed greatly to the advancement of fertility and reproductive medicine.

"It's quite likely that many women will be in the menopause for longer than their fertile period. We are empowering women to take control of their own health by naturally delaying their menopause,” says Professor Fishel.

“Now we can start to offer something to a younger generation of women that’s never been available before. ”

However, the treatment is still in its early stages of development, and there may be risks that haven’t been realised yet. The British Menopause Society (BMS) advised that more research needs to be done to evaluate the long-term effects and safety of the procedure.

“When it comes to considering this in the context of delaying the menopause, further evaluation is needed to assess the safety of this technique, its effectiveness and the length of time such re-implanted tissue continues to function,” says Haitham Hamoda, chairman of the BMS.

#whjnews #whjmedicaltechnology #whjlifesciences